Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Oral Cladribine in Early Multiple Sclerosis (MS)

ClinicalTrials.gov ID: NCT00725985

Public ClinicalTrials.gov record NCT00725985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS

Study identification

NCT ID
NCT00725985
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
EMD Serono Research & Development Institute, Inc.
Industry
Enrollment
617 participants

Conditions and interventions

Interventions

  • Cladribine Drug
  • Placebo Drug
  • Rebif® new formulation (RNF) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 30, 2008
Primary completion
Jul 30, 2011
Completion
Apr 29, 2012
Last update posted
Mar 21, 2021

2008 – 2012

United States locations

U.S. sites
24
U.S. states
17
U.S. cities
24
Facility City State ZIP Site status
Hope Research Institute Medical Plaza LLC Desert Hills Phoenix Arizona
Multiple Sclerosis Center Drive, Neurology Suite 701 Newport Beach California
University of Colorado at Denver Health Sciences Denver Colorado
Fort Collins Neurology Fort Collins Colorado
MS Center of Brevard MIMA Centry Research Associates Melbourne Florida
University of South Florida Tampa Florida
MS Center of Atlanta Atlanta Georgia
Bruce Hughes West Building Des Moines Iowa
Michigan Neurology Associates Clinton Township Michigan
Henry Ford Hospital Detroit Michigan
University of Minnesota Minneapolis Minnesota
Dennis Dietrich Great Falls Montana
University of Medicine and Dentistry of New Jersey School of Neurology Stratford New Jersey
Upstate Clinical Research LLC 3 Albany New York
Neurological Specialists of Long Island Great Neck New York
Multiple Sclerosis Center of Northeastern NY New York New York
Comprehensive MS Care Clinic at South Shore Multiple Sclerosis Patchogue New York
Carolinas Medical Center Charlotte North Carolina
Meritcare Neuroscience Center Neurology Fargo North Dakota
University of Cincinnati Cincinnati Ohio
MS Center of Oklahoma Oklahoma City Oklahoma
Neurology and Sleep Medicine Bethlehem Pennsylvania
Swedish Medical Center Cherry Hill Seattle Washington
Neurology & Neurological Association of Tacoma Tacoma Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 134 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00725985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00725985 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →